Clinical application value of prenatal inspection immunoassay items
产前检查免疫检验项目的临床应用及护理

摘要

目的 研究免疫检验项目在产前检查中的临床使用效果。方法 抽取204例妊娠期产妇作为研究对象，产妇抽取时间段介于2019年1月到2019年12月期间，均符合研究标准。需要研究人员将该204例产妇按照1:1的比例分为观察组（102例）与对照组（102例），研究期间需要护理人员做好记录工作，对照组妊娠期产妇运用常规检查，不做特殊处理；观察组妊娠期产妇运用免疫检验，根据检验结果进行治疗干预。对比两组产妇妊娠期间危险因素检出率、产后异常出血、静脉血栓、妊娠期高血压不良事件发生率。结果 观察组妊娠期产妇运用免疫检验且艾滋病、梅毒、乙肝以及丙肝的危险因素检测率为12.75%，而对照组妊娠期产妇运用常规检验危险因素检出率为2.94%，观察组妊娠期产妇危险因素检测率明显高于对照组，组间差异显著（P＜0.05）。此外，观察组妊娠期产妇根据检验结果行治疗干预后，产后异常出血、静脉血栓、妊娠期高血压不良事件发生率为9.8%，相较于对照组妊娠期产妇不良事件发生率37.25%低，数据对比存在差异，具有统计学意义（P＜0.05）。结论 在产妇妊娠期间采用免疫检验可以有效提升危险因素检测率，依据检验结果进行治疗干预，可以有效降低产后异常出血、静脉血栓、妊娠期高血压不良事件发生率，值得临床推广使用。

Abstract

Objective: To study the clinical effect of immunoassay items in prenatal examination.
Methods: A total of 204 pregnant women were selected as the research object. The period of maternal sampling was from January 2019 to December 2019, and all met the research standards. Researchers are required to divide the 204 women into an observation group (102 cases) and a control group (102 cases) according to a 1: 1 ratio. During the study, nurses are required to make records. The control group pregnant women use routine examinations, withoutspecial treatment; pregnant women in the observation group use immunoassays to intervene according to the test results. The rate of detection of risk factors during pregnancy, abnormal postpartum hemorrhage, venous thrombosis, and the incidence of adverse events of hypertension during pregnancy were compared between the two groups.
Results: The pregnant women in the observation group used immunological tests and the detection rate of risk factors for AIDS, syphilis, hepatitis B and C was 12.75%, while the pregnant women in the control group used routine tests to detect risk factors of 2.94%. The detection rate of risk factors of the pregnant women in the observation group was significantly higher than that of the control group, and the difference between the groups was significant (P <0.05). In addition, the incidence of abnormal postpartum hemorrhage, venous thrombosis, and pregnancy-induced hypertension during the intervention group of pregnant women in the observation group according to the test results was 9.8%, which was lower than the incidence rate of 37.25% in the control group. There is a difference in data comparison, which is statistically significant (P <0.05).
Conclusion  : Immunoassay during maternal pregnancy can effectively increase the detection rate of risk factors, and therapeutic intervention based on the test results can effectively reduce the incidence of abnormal postpartum hemorrhage, venous thrombosis, and adverse events of hypertension in pregnancy, which is worthy of clinical promotion.